TipRanks
YUNGJIN PHARM. CO. LTD (KR:003520)
:003520
South Korea Market
003520
YUNGJIN PHARM. CO. LTD
RESEARCH TOOLSreports

YUNGJIN PHARM. CO. LTD (003520) Ratios

― Followers

YUNGJIN PHARM. CO. LTD Ratios

KR:003520's free cash flow for Q2 2026 was ₩0.31. For the 2026 fiscal year, KR:003520's free cash flow was decreased by ₩ and operating cash flow was ₩-0.02. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.47 1.48 1.08 1.69 2.06
Quick Ratio
 0.64 0.81 0.46 0.86 1.08
Cash Ratio
 0.05 0.29 0.03 0.10 0.01
Solvency Ratio
 0.02 0.05 0.07 0.04 -0.13
Operating Cash Flow Ratio
 -0.04 0.10 0.19 -0.17 -0.23
Short-Term Operating Cash Flow Coverage
 -0.07 0.23 0.36 -0.50 -1.04
Net Current Asset Value
₩ -28.97B₩ -25.29B₩ -20.64B₩ -10.40B₩ -11.02B
Leverage Ratios
Debt-to-Assets Ratio
 0.34 0.36 0.28 0.30 0.19
Debt-to-Equity Ratio
 0.90 1.03 0.72 0.75 0.44
Debt-to-Capital Ratio
 0.47 0.51 0.42 0.43 0.30
Long-Term Debt-to-Capital Ratio
 0.31 0.35 0.05 0.31 0.23
Financial Leverage Ratio
 2.64 2.87 2.61 2.53 2.26
Debt Service Coverage Ratio
 0.14 0.25 0.23 0.28 -1.13
Interest Coverage Ratio
 -1.10 0.82 1.65 1.08 -10.00
Debt to Market Cap
 0.40 0.24 0.18 0.16 0.06
Interest Debt Per Share
 443.98 504.74 384.68 377.98 219.02
Net Debt to EBITDA
 16.45 5.37 3.65 7.80 -2.70
Profitability Margins
Gross Profit Margin
28.97%29.84%31.88%30.90%29.64%
EBIT Margin
-1.82%1.34%3.24%-0.44%-10.11%
EBITDA Margin
1.77%4.80%6.69%3.26%-6.55%
Operating Profit Margin
-1.71%1.34%3.46%1.33%-3.37%
Pretax Profit Margin
-3.10%-0.08%1.15%-1.67%-10.45%
Net Profit Margin
-2.47%-0.09%0.49%-1.65%-10.06%
Continuous Operations Profit Margin
-2.47%-0.09%0.49%-1.65%-10.06%
Net Income Per EBT
79.74%107.39%42.70%98.92%96.27%
EBT Per EBIT
180.89%-6.21%33.10%-125.68%309.82%
Return on Assets (ROA)
-2.75%-0.09%0.53%-1.71%-10.81%
Return on Equity (ROE)
-7.02%-0.25%1.37%-4.32%-24.44%
Return on Capital Employed (ROCE)
-2.87%2.08%7.29%2.06%-4.80%
Return on Invested Capital (ROIC)
-1.82%1.64%2.07%1.74%-4.29%
Return on Tangible Assets
-2.78%-0.09%0.53%-1.73%-10.96%
Earnings Yield
-3.28%-0.06%0.34%-0.97%-3.46%
Efficiency Ratios
Receivables Turnover
 5.72 5.00 5.12 4.34 4.14
Payables Turnover
 7.95 7.80 7.54 8.39 7.42
Inventory Turnover
 2.83 2.70 2.42 2.63 3.17
Fixed Asset Turnover
 2.50 2.45 2.57 2.75 2.55
Asset Turnover
 1.11 0.97 1.08 1.04 1.08
Working Capital Turnover Ratio
 6.10 9.03 8.31 4.51 4.65
Cash Conversion Cycle
 146.84 161.56 173.65 179.58 154.16
Days of Sales Outstanding
 63.85 72.94 71.23 84.11 88.20
Days of Inventory Outstanding
 128.89 135.41 150.81 138.99 115.13
Days of Payables Outstanding
 45.90 46.79 48.39 43.52 49.17
Operating Cycle
 192.74 208.35 222.04 223.10 203.33
Cash Flow Ratios
Operating Cash Flow Per Share
 -15.58 52.67 118.87 -67.73 -63.48
Free Cash Flow Per Share
 -45.58 -4.83 0.73 -123.20 -135.65
CapEx Per Share
 29.99 57.50 118.14 55.47 72.17
Free Cash Flow to Operating Cash Flow
 2.92 -0.09 <0.01 1.82 2.14
Dividend Paid and CapEx Coverage Ratio
 -0.52 0.92 1.01 -1.22 -0.88
Capital Expenditure Coverage Ratio
 -0.52 0.92 1.01 -1.22 -0.88
Operating Cash Flow Coverage Ratio
 -0.04 0.11 0.33 -0.19 -0.30
Operating Cash Flow to Sales Ratio
 -0.01 0.04 0.09 -0.05 -0.05
Free Cash Flow Yield
-4.37%-0.24%0.04%-5.66%-3.90%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -30.84 -1.61K 294.96 -103.57 -28.94
Price-to-Sales (P/S) Ratio
 0.75 1.53 1.44 1.71 2.91
Price-to-Book (P/B) Ratio
 2.21 4.25 4.05 4.48 7.07
Price-to-Free Cash Flow (P/FCF) Ratio
 -22.88 -413.90 2.72K -17.65 -25.62
Price-to-Operating Cash Flow Ratio
 -66.92 37.98 16.72 -32.11 -54.74
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 13.62 -2.23 1.26 -0.32
Price-to-Fair Value
 2.21 4.25 4.05 4.48 7.07
Enterprise Value Multiple
 59.06 37.26 25.20 60.27 -47.16
Enterprise Value
 264.41B 454.60B 425.23B 461.07B 674.19B
EV to EBITDA
 59.06 37.26 25.20 60.27 -47.16
EV to Sales
 1.05 1.79 1.69 1.96 3.09
EV to Free Cash Flow
 -31.72 -483.66 3.18K -20.28 -27.17
EV to Operating Cash Flow
 -92.76 44.38 19.56 -36.89 -58.07
Tangible Book Value Per Share
 458.36 461.03 481.81 473.14 476.74
Shareholders’ Equity Per Share
 471.08 470.19 491.02 485.68 491.38
Tax and Other Ratios
Effective Tax Rate
 0.20 -0.07 0.57 0.01 0.04
Revenue Per Share
 1.38K 1.31K 1.38K 1.27K 1.19K
Net Income Per Share
 -34.20 -1.17 6.74 -21.00 -120.08
Tax Burden
 0.80 1.07 0.43 0.99 0.96
Interest Burden
 1.70 -0.06 0.35 3.76 1.03
Research & Development to Revenue
 0.03 0.04 0.05 0.06 0.07
SG&A to Revenue
 0.13 0.12 0.11 0.10 0.10
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.46 -45.00 17.64 3.23 0.53
Currency in KRW